Healthcare analytics is the analysis of healthcare activities and data collected from the different area of healthcare. Analytics help healthcare organizations to coordinate better and improve patient wellness. The main benefit of using healthcare analytics is to help you in decision making, which will increase patient experience and outcomes in a cost-effective manner.
Healthcare is going through the "data revolution or information revolution". Healthcare organizations are quickly embracing data frameworks to enhance both business operations and clinical care.
Many classes of information systems are rising within the healthcare area, ranging from electronic medical records (EMRs), and specialty care software, to supply chain control structures. In healthcare, there is always a need for accurate, timely, and comfortably availability of information at some phase in the organization and for different purposes.
When it comes to healthcare analytics, hospitals and health systems can benefit most from the information if they move towards understanding the analytic discoveries, rather than simply centering at the quick measurements.
Pressures on the healthcare system are mounting – from both the money related and clinical viewpoints. In many cases, healthcare executives are being called upon to settle on quick decisions to streamline operations and to identify and adapt to emerging healthcare needs. Furthermore, obviously, those decisions are expected to be the right so these choices rely upon the information derived from healthcare analytic systems.
Along with this demand for data to improve decision-making in healthcare, however, is a demand for analysis of the medical data.
Healthcare analytics software and big data solutions can greatly improve patient outcomes and address biggest priorities of healthcare systems.
Examining large volumes of medical and operational data can be helpful to predict and medically investigate potential issues before they become a reality in patient safety signals.
White Paper By: LiveProcess
A Continuity of Operations Plan (COOP) ranks the essential business functions an organization must perform even in an emergency and then puts in place means for ensuring that they continue. A COOP ensures that the need to plan for both more complex patient care issues and a higher level of community coordination are taken into account for emergency preparedness planning. A COOP also...
White Paper By: Group One Health Source
Medical billing has proven to be one of the most complex and crucial components as the recent industry changes have added many challenges and complexities to the business of the medical practice. Aside from clinical services, revenue cycle management is the most important process of a medical practice. The decision to outsource medical billing should not be taken lightly. This...
White Paper By: SHYFT Analytics, Inc.
Why Real World Evidence (RWE) is important to drive improvements in patient outcomes? Real World Evidence (RWE) has long been heralded as a “game changer” for the life sciences industry. Real World Evidence is the term used to describe research findings that use data that is gathered outside of standard clinical trials. This informative whitepaper highlights the...
The Value of the State Immunization Registry Program to Improve Vaccination Rates and Quality of Care in Retail Pharmacies
White Paper By: Scientific Technologies Corporation
The state immunization registry, or immunization information system (IIS), is an important resource for consolidated patient immunization records so that vaccination providers can access this information.Over the years state immunization registry have evolved into sophisticated data management and clinical decision support tools for vaccination providers. Read this informative whitepaper...
Biomarkers and Acute Kidney Injury (AKI): Pre-analytical Considerations are Critical for Early Detection of AKI
White Paper By: Pacific Biomarkers
Biomarkers for the prediction of acute kidney injury: A review on current status and future challenges Biomarker of acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in critically ill patients. The approach to analyzing AKI biomarkers has been to provide pharmaceutical and biotech companies with services for testing robust novel biomarkers that...
White Paper By: Pacific Biomarkers
Testing for incretins, and other gut hormones, presents numerous challenges because of their instability. Therefore, proper sample collection and meticulous pre-analytical and analytical sample handling are crucial for successful quantification of these biomarkers. Incretins, which are insulinotropic gastrointestinal hormones, are produced mainly in K and L cells of the small intestine under...